Since its inception in 1992, Medpace has leveraged its therapeutic and regulatory expertise to successfully partner with leading pharmaceutical and biotechnology companies to bring promising new drugs to the market. In view of the ever increasing demand for faster and higher-quality clinical safety data and disease-related biomarkers, Medpace expanded its services portfolio to include a full-service central laboratory called Medpace Reference Laboratories (MRL).

MRL combines the established strength of the Medpace global clinical development company, a state-of-the-art infrastructure, and an excellent staff of scientists and technical specialists with extensive experience in all areas of the central laboratory business. Our experience includes coagulation, cardiovascular diseases, oncology, lipids, diabetes, and other metabolic diseases.

Our sole objective is to become the world's leading provider of customized quality laboratory services, dedicated to science and service, not to marketing and volume. We recognize the importance of flexibility in programming, specimen management, data processing, and reporting of laboratory data to the success of a clinical trial.

Explore our website to learn more about MRL and our high-quality services portfolio.

To logon to our web-based laboratory data access and report portal, please visit
ClinTrak Lab^®, our Lab Information Management System.